Today: 9 April 2026
Santander stock drops on Openbank fine report — what to watch before Monday trade
25 January 2026
1 min read

Santander stock drops on Openbank fine report — what to watch before Monday trade

Madrid, January 25, 2026, 00:01 CET — Market closed

  • Santander shares dropped 1.45% on Friday following reports of a fine from a Spanish watchdog related to Openbank processes
  • Markets are digesting the ECB’s rate outlook as new euro zone business surveys highlight stronger price pressures
  • Attention shifts to Santander’s Feb. 4 results presentation, with investors keen on any new details about compliance controls

Shares of Banco Santander slipped 1.45%, ending Friday at 10.48 euros following news that Spain’s anti-money-laundering authority fined its digital unit, Openbank, over prior internal process lapses. santander.com

The timing couldn’t be worse for Santander’s digital growth story. Openbank, key to the lender’s expansion strategy, faces a setback just as the bank aims to roll out more consumer finance products under that brand across several markets. Cinco Días

Spanish media reports the matter goes back several years, with Santander contesting the fine. The bank insists the review isn’t connected to any money-laundering allegations but focuses on procedural issues, especially involving inactive accounts. elconfidencial.com

Rate expectations are driving the action. A key euro zone business survey revealed steady activity growth in January, with input costs and selling prices both rising — factors that leave the European Central Bank’s next steps uncertain for banks reliant on interest rates. “Overall, these are decent data,” said Claus Vistesen, chief euro zone economist at Pantheon Macroeconomics. Reuters

ECB policymaker Martin Kocher sounded a note of caution on Friday, warning against taking action before risks actually emerge. Markets are now pricing in steady rates through 2026. “I would be cautious,” Kocher said. Reuters

Santander’s shares saw a sharp move late in the week. On Thursday, they jumped 2.98%, but then slipped back on Friday, fluctuating between 10.444 and 10.598 euros. Around 15.16 million shares traded hands, according to exchange data from Investing.com. By week’s end, the stock was down roughly 0.6%. Investing.com

Santander’s slide put it behind the wider Madrid market. Spain’s IBEX 35 dropped 0.67% on Friday, with European stocks poised for a weekly loss amid simmering geopolitical tensions and uneven economic data. MarketScreener

A major concern for bulls is whether the Openbank problem turns into something bigger than just a one-off setback. The fine might be manageable, but traders usually react harshly when compliance issues arise, particularly since digital growth depends heavily on seamless onboarding and strict customer controls.

Trading is paused for the weekend, but investors will be eyeing any new updates on the Openbank case. They’re also looking out for fresh clues on the ECB’s direction, which could quickly reshape bank valuations through changes in bond yields and margin forecasts.

Santander’s Q4 results drop on Feb. 4 is shaping up as the next crucial event. Investors want to hear about regulatory issues at Openbank and get a read on what’s expected to drive earnings in 2026. santander.com

Stock Market Today

  • Guard Therapeutics Faces Potential Delisting from Nasdaq First North Growth Market
    April 9, 2026, 12:06 PM EDT. Guard Therapeutics International AB has been notified by Nasdaq that it currently fails to meet the active operations requirement, risking delisting by June 17, 2026. The company is exploring a merger or reverse acquisition to satisfy Nasdaq's operational criteria. A transaction structure is expected to be proposed in Q2 2024, allowing Nasdaq to reassess the listing status. If no agreement is reached, the board will recommend voluntary delisting and liquidation, returning available funds to shareholders. Final decisions will be taken by shareholders at a general meeting. Guard Therapeutics focuses on developing therapies for kidney diseases based on the alpha-1-microglobulin protein and is listed under the ticker GUARD.

Latest article

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

9 April 2026
Palantir Technologies dropped about 7% Thursday after Michael Burry said Anthropic was overtaking it in enterprise AI, putting Palantir on track to lose $34 billion in market value. Anthropic reported its annualized revenue run rate had surged past $30 billion and launched new AI tools for businesses. Nearly one in four businesses on Ramp now pays for Anthropic, according to Ramp data. Palantir’s stock still trades at 395 times earnings.
Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

9 April 2026
Salesforce shares hit a new 52-week low Thursday, dropping 3.7% to $169.76 despite reporting 12% revenue growth and strong demand for its AI products. The broader software sector continued to slide, with the S&P 500 software and services index down about $1 trillion since January. Salesforce raised its buyback authorization to $50 billion and increased its dividend to 44 cents a share.
ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

9 April 2026
ServiceNow shares dropped 5.1% to $92.45 by 10:20 a.m. EDT Thursday, hitting a new 52-week low after analysts at Stifel, BTIG, and Goldman Sachs cut price targets citing weak federal spending and limited 2026 growth. The company announced it will integrate AI, data, security, and governance into all products ahead of first-quarter results due April 22.
SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

9 April 2026
SoFi Technologies shares fell 1.9% to $16.18 Thursday after KBW and Wells Fargo cut price targets ahead of first-quarter results due April 29. The moves follow Muddy Waters’ short position and claims of accounting issues, which SoFi denies. Affirm and LendingClub also traded lower. Barclays and other banks have trimmed targets as concerns mount over credit quality and sector valuations.
Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

9 April 2026
Tesla is developing a smaller, cheaper electric SUV to be built first in Shanghai, sources said. The new model would cost less than the Model 3 and be smaller than the Model Y. Tesla produced 408,386 vehicles but delivered only 358,023 in Q1, as U.S. demand weakened and competition increased. Shares fell 0.8% Thursday.
GE Vernova stock price: GEV heads into earnings week after Power segment CEO exit
Previous Story

GE Vernova stock price: GEV heads into earnings week after Power segment CEO exit

Shopify stock price: 3 things investors watch after Friday’s close
Next Story

Shopify stock price: 3 things investors watch after Friday’s close

Go toTop